Noventra Pharma Tirzepatide (60mg GLP?1 & GIP Peptide – Premium White Series)

Tirzepatide 60mg (Premium White Series) by Noventra Pharma is a high-strength peptide formulation designed to support appetite regulation, metabolic efficiency, and advanced body composition optimisation. Tirzepatide is a dual incretin receptor agonist, targeting both GLP?1 (glucagon-like peptide?1) and GIP (glucose-dependent insulinotropic polypeptide) pathways to deliver a synergistic metabolic effect. This dual mechanism enhances insulin sensitivity, reduces glucagon release, slows gastric emptying, and promotes prolonged satiety, contributing to reduced caloric intake and improved metabolic balance. Tirzepatide is widely regarded as a next-generation metabolic peptide, with clinical data demonstrating significant weight reduction and improved glycaemic control compared to single-pathway GLP?1 agonists. With an extended half-life of approximately 5 days, this peptide supports once-weekly dosing, maintaining stable activity levels and consistent metabolic regulation. The 60mg formulation is typically positioned for longer-duration protocols or higher-capacity dosing cycles, offering flexibility for structured weight management, metabolic optimisation, and performance-focused applications. Key Features: - 60mg tirzepatide high-strength formulation - Dual incretin agonist: GLP?1 & GIP receptor activity - Supports appetite suppression and satiety control - Promotes improved insulin sensitivity and glucose regulation - Associated with enhanced fat metabolism and body composition - Long-acting peptide (~5-day half-life) for sustained effect - Suitable for extended or higher-capacity dosing protocols - Premium White Series formulation Suggested Use: Typically administered once weekly in controlled doses as part of a structured protocol. Dosing is usually titrated gradually based on tolerance and individual response. Usage should be guided by a qualified healthcare provider. Storage: Refrigerate at 2–8°C. Protect from light. Do not freeze. Important Information: This product is intended for use under medical supervision only. Tirzepatide is a prescription-based compound in many regions and may not be suitable for individuals with certain medical conditions, including type 1 diabetes or a history of specific endocrine disorders. Common side effects may include nausea, gastrointestinal discomfort, or fatigue. Always consult a qualified healthcare provider before use.